U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07368504) titled 'AI for Newborn Metabolic Screening' on Jan. 16.
Brief Summary: The goal of this clinical trial is to evaluate whether an artificial intelligence (AI)-based interpretation system can accurately diagnose inherited metabolic disorders in newborns undergoing routine screening. The main questions it aims to answer are:
What is the sensitivity and specificity of the AI system compared to standard manual interpretation? Does the AI system reduce variability in screening results? Researchers will compare the AI interpretation results with those from standard manual review by trained laboratory staff to assess diagnostic performance.
Parti...